Zhitong Finance App News, Changshan Pharmaceutical (300255.SZ) issued an announcement. The company recently received a notice from the European Union Croatian Medicines and Medical Devices Administration (HALMED) of the end of the decentralized approval procedure (DCP) procedure. The company's enoxaparin sodium injection has passed the review by the Croatian Drug and Medical Device Administration. This drug is used to prevent venous thromboembolic diseases, treat formed deep venous embolisms, etc.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.